Panimaloy, Norhaney -.
HRN: 24-62-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2024
OXACILLIN 500MG (VIAL)
03/18/2024
03/25/2024
IV
200mg
Q6H
Cellulitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes